Medical Aid Recipients and Low-Income Groups Supported Up to 3 Million Won Annually

Geochang-gun Expands Medical Expense Support for Low-Income Cancer Patients View original image

[Asia Economy Yeongnam Reporting Headquarters Reporter Choi Soon-kyung] Geochang-gun, Gyeongnam announced on the 15th that it will provide medical expense support based on the revised standards starting July 1, in accordance with the Ministry of Health and Welfare's revised notification on medical expense support criteria for cancer patients.


Under this revision, the annual support limit for medical aid recipients and low-income health insurance beneficiaries subject to reduced personal burden will be expanded from a maximum of 2.2 million KRW to 3 million KRW (for three years), and the distinction between support for insured and uninsured medical expenses has been eliminated.


Additionally, among those in the bottom 50% of health insurance premiums, adult cancer patients diagnosed through the national cancer screening program will experience reduced medical expenses due to strengthened health insurance coverage, and considering the existence of similar support programs, new support will be discontinued starting this month.


However, those who underwent national cancer screening by June 30, 2021, and were diagnosed with one of the five major cancers within two years or diagnosed with lung cancer within the same period can apply for support under the existing criteria, with a maximum annual support of up to 2 million KRW for insured personal expenses (for three years).



Gu In-mo, the mayor of Geochang-gun, stated, “With the expanded support limit for cancer treatment costs, we can provide more help to those urgently in need of treatment expenses,” and added, “We will do our best to support medical expenses and promote awareness to reduce the economic burden on low-income cancer patients.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing